BENEDETTI, LUANA
 Distribuzione geografica
Continente #
EU - Europa 1.103
Totale 1.103
Nazione #
IT - Italia 1.103
Totale 1.103
Città #
Genova 385
Genoa 367
Rapallo 222
Vado Ligure 112
Bordighera 17
Totale 1.103
Nome #
Dysimmune mononeuropathies: A diagnosis not to be missed 145
N-methyl-D-aspartate receptor antibody-related pathologies and pre-existent mental state disorders 74
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. 70
Regional variation of Guillain-Barré syndrome 65
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. 62
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 55
NERVE ULTRASOUND AND 3-TESLA MAGNETIC RESONANCE IMAGING FINDINGS IN NODO-PARANODOPATHIES: CORRELATION WITH CLINICAL AND NEUROPHYSIOLOGICAL EXAMINATIONS 54
COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series 50
null 48
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 46
Impact of environmental factors and physical activity on disability and quality of life in CIDP 44
I can’t count, but I can beat you playing cards: a case report on autoimmune encephalitis 42
null 41
ATYPICAL STIFF PERSON SYNDROME WITH ANTI-IGLON5 ANTIBODIES: A CASE REPORT 40
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 40
FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative Analysis 38
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy 35
Are basketball players more likely to develop Hirayama disease? 34
Neurological long-COVID in the outpatient clinic: Two subtypes, two courses 34
Improving laboratory diagnostics in myasthenia gravis 28
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 27
Patients With Suspected Severe Adverse Reactions to COVID-19 Vaccination Admitted to Intensive Care Unit: A Case Report 21
DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS 20
Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments 14
An aggressive form of MOGAD treated with aHSCT: A case report 14
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 8
Patient With Rigidity and Fasciculations 7
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis 6
OUTCOMES AFTER SINGLE-CYCLE RITUXIMAB MONOTHERAPY IN PATIENTS WITH ANTI-MAG ANTIBODY POLYNEUROPATHY: A 11 YEARS FOLLOW-UP ANALYSIS 5
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score 4
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 3
Incident anti-LGI1 autoimmune encephalitis during dementia with Lewy bodies: when Occam razor is a double-edged sword 3
Cervical alterations in Hirayama disease: an MRI and FDG-PET combined approach 2
Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory 2
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 1
Totale 1.182
Categoria #
all - tutte 5.985
article - articoli 5.985
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 2 2 7 6 8 9 16 11 5
2020/2021138 5 18 6 18 8 5 8 17 7 24 12 10
2021/2022169 21 2 0 4 9 13 11 31 23 20 6 29
2022/2023262 17 33 3 31 19 45 5 19 41 6 38 5
2023/2024344 13 18 23 70 17 69 23 29 10 14 16 42
2024/2025154 66 66 22 0 0 0 0 0 0 0 0 0
Totale 1.182